Sort   by:  
 Page size 
UnknownPERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Not available
S-EPMC9292306 | biostudies-literature
UnknownThe safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Not available
S-EPMC9292935 | biostudies-literature
UnknownEptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Not available
S-EPMC9542908 | biostudies-literature
UnknownX Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.
Not available
S-EPMC8169555 | biostudies-literature
Sort   by:  
 Page size